• Products
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Trading Platforms
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Trading Platforms
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Market Movers
    Share Market Today
    Top Gainers
    Top Losers
    Stocks
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Market Movers
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Stockshaala
    Basics of Stock Market
    Introduction to Fundamental Analysis
    Introduction to Technical Analysis
    Derivatives, Risk management & Option Trading Strategies
    Personal Finance
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Stockshaala
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
​

Alpa Laboratories Ltd's Q4FY25 Quarter Results

Alpa Laboratories Ltd's revenue decreased 3.2% YoY
  • 30 May 2025
  • Alpa Laboratories Ltd reported a 21.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 3.2%.
  • Its expenses for the quarter were down by 19.7% QoQ and up 1.9% YoY.
  • The net profit decreased 60.1% QoQ and decreased 23.7% YoY.
  • The earnings per share (EPS) of Alpa Laboratories Ltd stood at 1.7 during Q4FY25.
(₹ crores) Q4FY25 Q3FY25 Q4FY24 QoQ (%) YoY (%)
Total Income
27.57
34.95
28.47
-21.1%
-3.2%
Total Expenses
20.91
26.05
20.52
-19.7%
1.9%
Profit Before Tax
6.67
8.90
7.96
-25.1%
-16.2%
Tax
3.12
0.00
3.31
-
-5.7%
Profit After Tax
3.55
8.90
4.65
-60.1%
-23.7%
Earnings Per Share
1.70
4.20
2.10
-59.5%
-19.0%

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Alpa Laboratories Ltd is a company whose primary business operations and industry classification are not specified in the provided data. There is no detailed information available regarding the main products or services offered by Alpa Laboratories Ltd, nor are there any recent major developments mentioned. Without these specifics, the company’s strategic focus, market position, or changes in its business environment remain unaddressed.

During Q4FY25, Alpa Laboratories Ltd reported a total income of ₹27.57 crores, a decrease of 21.1% from the previous quarter (Q3FY25) where the income was ₹34.95 crores. When compared to the same quarter in the previous year (Q4FY24), the income showed a decline of 3.2% from ₹28.47 crores. The year-over-year (YoY) and quarter-over-quarter (QoQ) changes indicate fluctuations in revenue within the timeframe, marking a decrease in both cases.

The Profit Before Tax (PBT) for Q4FY25 was ₹6.67 crores, showing a decrease of 25.1% from the previous quarter's ₹8.90 crores and a decline of 16.2% from ₹7.96 crores in Q4FY24. The company’s tax expenses for Q4FY25 amounted to ₹3.12 crores, which showed no change from Q3FY25 due to unavailable data, but showed a decrease of 5.7% from the previous year's same quarter. Profit After Tax (PAT) dropped significantly by 60.1% quarter-over-quarter from ₹8.90 crores in Q3FY25 to ₹3.55 crores in Q4FY25, and also showed a year-over-year decrease of 23.7% compared to ₹4.65 crores in Q4FY24. Earnings Per Share (EPS) followed a similar trend, declining by 59.5% QoQ from ₹4.20 to ₹1.70 and by 19.0% YoY from ₹2.10.

The total expenses reported in Q4FY25 were ₹20.91 crores, reflecting a decrease of 19.7% from the previous quarter's ₹26.05 crores. When compared to the same quarter in the previous year, expenses showed a slight increase of 1.9% from ₹20.52 crores. This suggests a cost structure that has seen reduction quarter over quarter but remains slightly elevated year over year. The financial data demonstrates fluctuations in key operating metrics, including a reduction in income and profitability metrics across the board, indicating a variance in the company's financial performance over the specified periods.

Open Demat Account
+91 -

Open Demat Account
+91 -